DEFA14A: Aprea Therapeutics Sets Date for 2024 Annual Meeting, Outlines Voting Matters
Proxy Statement
Aprea Therapeutics announces its 2024 Annual Meeting of Stockholders to be held virtually on June 20, 2024, with key voting items including the election of directors and ratification of the company's accounting firm.
Summary
- Aprea Therapeutics has scheduled its Annual Meeting of Stockholders for June 20, 2024, at 9:00 A.M. Eastern Time, to be held virtually.
- Stockholders are being asked to vote on the election of three Class II directors: Michael Grissinger, Gabriela Gruia, M.D., and Rifat Pamukcu, M.D.
- The ratification of EisnerAmper LLP as the company's independent registered public accounting firm for fiscal year 2024 is also up for vote.
- Proxy materials are available online, and stockholders can request a free paper or email copy before June 6, 2024.
- The voting deadline is June 19, 2024, at 11:59 PM ET.
Sentiment
Score: 7
Explanation: The document is a routine announcement of an annual meeting and voting matters, indicating a neutral to slightly positive sentiment as it reflects standard corporate governance practices.
Positives
- The virtual format of the annual meeting allows for broader accessibility for stockholders.
- Stockholders have multiple options for accessing proxy materials and voting, including online, phone, and email.
Future Outlook
The document outlines the matters to be voted on at the upcoming annual meeting, providing a framework for the company's governance and financial oversight for the coming year.
Industry Context
This announcement is a standard part of corporate governance, ensuring that shareholders have the opportunity to participate in key decisions regarding the company's direction and oversight.
Stakeholder Impact
- Shareholders have the opportunity to influence the company's direction through voting on key proposals.
- The outcome of the votes will impact the composition of the board of directors and the selection of the company's accounting firm.
Next Steps
- Stockholders to review proxy materials and cast their votes by the deadline.
- Aprea Therapeutics to hold the Annual Meeting on June 20, 2024.
Key Dates
| Date | Description |
|---|---|
| June 6, 2024 | Deadline to request a paper or email copy of proxy materials. |
| June 19, 2024 | Voting deadline at 11:59 PM ET. |
| June 20, 2024 | Annual Meeting of Stockholders at 9:00 A.M. Eastern Time. |
Keywords
Annual Meeting, Proxy Statement, Stockholders, Directors, EisnerAmper, Voting, Aprea Therapeutics
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.